HRT Financial’s Medtronic MDT Stock Holding History

HRT Financial’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.42M	Buy	+108,700	New	+$10.4M	0.02%	647

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HRT Financial's MDT Position: Q1 2026 in Review

HRT Financial sold out of Medtronic (MDT) in Q1 2026, closing a stake of 26,232 shares — an estimated $2.51M sold.

HRT Financial first reported a position in MDT in Q4 2017 and held it in 22 quarters. The position peaked at $79.3M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

HRT Financial reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
HRT Financial sold 26,232 Medtronic shares in Q1 2026, an estimated $2.51M.
HRT Financial first reported a position in Medtronic in Q4 2017 and held it in 22 quarters.
HRT Financial's Medtronic position peaked at $79.3M in Q3 2024.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.